Huge volume18 Feb 2021 12:43
MGC describes itself as a bio-pharma company “specialising in the production and development of phytocannabinoid-derived medicines.” In short, a medicinal cannabis business.
Last week, MGC became the first company in this very niche sector to IPO in London.